SupplySide West: On Record With FDA's Cara Welch
FDA continues to inspect dietary supplement firms to ensure compliance with manufacturing regulations, but an agency official said the level of noncompliance today—and ignorance of requirements adopted nearly a decade ago—are inexcusable.
November 10, 2016
FDA continues to inspect dietary supplement firms to ensure compliance with manufacturing regulations, but an agency official said the level of noncompliance today—and ignorance of requirements adopted nearly a decade ago—are inexcusable.
In this video recorded at SupplySide West in Las Vegas, Cara Welch, Ph.D., senior advisor to FDA’s Office of Dietary Supplement Programs, discussed some important regulatory matters, including:
- Compliance with cGMPs (current Good Manufacturing Practices);
- And the 2016 draft new dietary ingredient (NDI) guidance.
You May Also Like